SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-17-317880
Filing Date
2017-10-24
Accepted
2017-10-24 16:14:02
Documents
3
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV5 LLCMPM BIOVENTURES V GP LLCMPM BIOVENTURES V LLCTODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13D d477521dsc13d.htm SC 13D 157843
2 EX-99.B d477521dex99b.htm EX-99.B 15518
3 EX-99.C d477521dex99c.htm EX-99.C 8716
  Complete submission text file 0001193125-17-317880.txt   183958
Mailing Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address MPM ASSET MANAGEMENT 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 (617) 425-9200
MPM BIOVENTURES V, L.P. (Filed by) CIK: 0001482716 (see all company filings)

IRS No.: 270793842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Subject) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90134 | Film No.: 171151095
SIC: 2834 Pharmaceutical Preparations